WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016178900) OCULAR IMPLANT FOR DELIVERY OF PYRIDINECARBOXAMIDE DERIVATIVE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/178900    International Application No.:    PCT/US2016/029754
Publication Date: 10.11.2016 International Filing Date: 28.04.2016
IPC:
A61K 31/535 (2006.01)
Applicants: ODIN BIOTECH [US/US]; 4000 Hanover Street Dallas, Texas 75225 (US).
SANTEN PHARMACEUTICAL CO., LTD [JP/JP]; 9-19, Shimoshinjo 3-Chome Higashiyodogawa-Ku, Osaka 533-8651 (JP)
Inventors: CSAKY, Karl; (US).
MUDUMBA, Sreenivasu; (US).
OBATA, Sayo; (JP).
YAMADA, Kazuhito; (JP)
Agent: WARD, Donna T.; (US)
Priority Data:
62/155,632 01.05.2015 US
Title (EN) OCULAR IMPLANT FOR DELIVERY OF PYRIDINECARBOXAMIDE DERIVATIVE
(FR) IMPLANT OCULAIRE POUR L'ADMINISTRATION DE DÉRIVÉ PYRIDINE-CARBOXAMIDE
Abstract: front page image
(EN)The present invention generally relates to local therapies for the eye and, more particularly, to shaped controlled-release ocular implant devices, including methods for making and using such devices, for delivery of 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4 -(trifluoromethoxy)phenyl]-3-pyridinecarboxamide (referred to as Formula I) or a salt thereof, to the eye. This implant is for placement in the sub-Tenon's space of the eye and provides sustained release of the compound for the treatment or prevention of a disorder of the eye.
(FR)La présente invention porte, d'une manière générale, sur des traitements locaux de l’œil et, plus particulièrement, des dispositifs d'implants oculaires formés à libération contrôlée, y compris des procédés de fabrication et d'utilisation de tels dispositifs, pour l'administration dans l’œil du 2-[[[2-[(hydroxyacétyl)amino]-4-pyridinyl]méthyl]thio]-N-[4-(trifluorométhoxy)phényl]-3-pyridine carboxamide (formule I) ou un sel de celui-ci. Cet implant est destiné à être placé dans l'espace sous-ténonien de l’œil et permet une libération prolongée du composé pour le traitement ou la prévention d'un trouble de l’œil.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)